Home/Filings/4/0001019056-18-000291
4//SEC Filing

Stromatt Scott C 4

Accession 0001019056-18-000291

CIK 0001671584other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 7:23 PM ET

Size

6.9 KB

Accession

0001019056-18-000291

Insider Transaction Report

Form 4
Period: 2018-02-03
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-03+27,381174,576 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-02-0327,38146,430 total
    Common Stock (27,381 underlying)
Footnotes (2)
  • [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
  • [F2]On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018.

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeother

Related Parties

1
  • filerCIK 0001679975

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:23 PM ET
Size
6.9 KB